Hormone-related factors and gynecological conditions in relation to endometrial cancer risk
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The objective of this study is to investigate the effect of menstrual and reproductive variables, breastfeeding, exogenous hormones, and gynecological conditions on endometrial cancer risk. We conducted a case-control study in Italy, including 454 women with endometrial cancer and 908 hospital controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariate logistic regression models. Endometrial cancer risk was inversely associated with age at menarche (OR = 0.7, 95% CI = 0.5-1.0, for > or =14 vs. <12 years), and directly associated with age at menopause (OR = 1.8, 95% CI = 1.1-2.7, for > or =55 vs. <50 years) and years of menstruation (OR = 2.4, 95% CI = 1.7-3.4, for highest vs. lowest tertile). Multiparity strongly reduced the risk among women under 60 years of age (OR = 0.3, 95% CI = 0.2-0.6, for > or =3 deliveries vs. <2). Oral contraceptive use conferred a 40% reduced risk (95% CI = 0.4-1.0), irrespective of time since cessation. Although based on small numbers, women with a history of treated infertility (OR = 2.7, 95% CI = 1.1-6.4) or endometriosis (OR = 4.0, 95% CI = 1.0-15.5) were at increased risks. No significant associations with endometrial cancer risk emerged for age at first/last birth, breastfeeding, menopausal status, hormone replacement therapy, and history of uterine fibromyomas or polycystic ovary. In conclusion, this study confirms the importance of multiparity, years of menstruation, and oral contraceptive use in endometrial cancer etiology, thus contributing to identify women at elevated risk of such neoplasm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Research works printed but not linked: 27
- Allen, 2008, Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC), Endocr Relat Cancer, 15, 485, 10.1677/ERC-07-0064 · DOI · Paper page
- Althuis, 2005, Uterine cancer after use of clomiphene citrate to induce ovulataion, Am J Epidemiol, 161, 607, 10.1093/aje/kwi084 · DOI
- Amant, 2005, Endometrial cancer, Lancet, 366, 491, 10.1016/S0140-6736(05)67063-8 · DOI · Paper page
- Beral, 2005, Endometrial cancer and hormone-replacement therapy in the Million Women Study, Lancet, 365, 1543, 10.1016/S0140-6736(05)66455-0 · DOI · Paper page
- Bosetti, 2001, Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls, J Clin Epidemiol, 54, 902, 10.1016/S0895-4356(01)00362-6 · DOI
- Bray, 2005, Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention, Cancer Epidemiol Biomarkers Prev, 14, 1132, 10.1158/1055-9965.EPI-04-0871 · DOI · Paper page
- Brinton, 1997, Cancer risk after a hospital discharge diagnosis of endometriosis, Am J Obstet Gynecol, 176, 572, 10.1016/S0002-9378(97)70550-7 · DOI · Paper page
- Brinton, 2007, Reproductive risk factors for endometrial cancer among Polish women, Br J Cancer, 96, 1450, 10.1038/sj.bjc.6603731 · DOI
- Chavez-MacGregor, 2008, Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women, Breast Cancer Res Treat, 108, 101, 10.1007/s10549-007-9574-z · DOI
- Chubak, 2004, Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations, Cancer Epidemiol Biomarkers Prev, 13, 1296, 10.1158/1055-9965.1296.13.8 · DOI
- Doherty, 2007, Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer, Am J Obstet Gynecol, 197, e1, 10.1016/j.ajog.2007.01.019 · DOI
- Key, 1988, The dose-effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk, Br J Cancer, 57, 205, 10.1038/bjc.1988.44 · DOI · Paper page
- Klip, 2000, Cancer risk associated with subfertility and ovulation induction: a review, Cancer Causes Control, 11, 319, 10.1023/A:1008921211309 · DOI
- Lucenteforte, 2008, Macronutrients, fatty acids and cholesterol intake and endometrial cancer, Ann Oncol, 19, 168, 10.1093/annonc/mdm446 · doi:10.1093/annonc/mdm446
- McPherson, 1996, Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study, Am J Epidemiol, 143, 1195, 10.1093/oxfordjournals.aje.a008707 · DOI · Paper page
- Navaratnarajah, 2008, Polycystic ovary syndrome and endometrial cancer, Semin Reprod Med, 26, 62, 10.1055/s-2007-992926 · DOI · Paper page
- Newcomb, 2000, Breast feeding practices in relation to endometrial cancer risk, USA, Cancer Causes Control, 11, 663, 10.1023/A:1008978624266 · DOI
- Okamura, 2006, Lactation and risk of endometrial cancer in Japan: a case-control study, Tohoku J Exp Med, 208, 109, 10.1620/tjem.208.109 · DOI
- Olson, 2002, Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study, Cancer, 94, 1612, 10.1002/cncr.10370 · DOI · Paper page
- Parazzini, 1998, Role of reproductive factors on the risk of endometrial cancer, Int J Cancer, 76, 784, 10.1002/(SICI)1097-0215(19980610)76:6<784::AID-IJC2>3.0.CO;2-U · DOI
- Parazzini, 2001, Risk of endometrial cancer after use of fertility drugs, Hum Reprod, 16, 196, 10.1093/humrep/16.1.196 · doi:10.1093/humrep/16.1.196
- Pike, 2004, Prevention of cancers of the breast, endometrium and ovary, Oncogene, 23, 6379, 10.1038/sj.onc.1207899 · DOI
- Pillay, 2006, The association between polycystic ovaries and endometrial cancer, Hum Reprod, 21, 924, 10.1093/humrep/dei420 · DOI · Paper page
- Shlesselman, 1997, Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis, Hum Reprod, 12, 1851, 10.1093/humrep/12.9.1851 · DOI · Paper page
- Strom, 2006, Case-control study of postmenopausal hormone replacement therapy and endometrial cancer, Am J Epidemiol, 164, 775, 10.1093/aje/kwj316 · DOI
- Wernli, 2006, Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women, Cancer Causes Control, 17, 949, 10.1007/s10552-006-0034-6 · DOI
- Xu, 2004, Menstrual and reproductive factors and endometrial cancer risk: Results from a population-base case-control study in urban Shanghai, Int J Cancer, 108, 613, 10.1002/ijc.11598 · DOI
Cited by
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., González-Martín, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv484 · Cited by 1,386
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., Gonzalez-Martin, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., et al. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000609 · Cited by 767
Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu012 · Cited by 597
Endometriosis: a high-risk population for major chronic diseases?
Kvaskoff, M., Mu, F., Terry, K. L., Harris, H. R., Poole, E. M., Farland, L., & Missmer, S. A. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv013 · Cited by 439
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L. V., Shigesi, N., Terry, K. L., Harris, H. R., Roman, H., Becker, C. M., As-Sanie, S., Zondervan, K. T., et al. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa045 · Cited by 303
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis
Millán-de-Meer, M., Luque-Ramírez, M., Nattero-Chávez, L., & Escobar-Morreale, H. F. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad015 · Cited by 82
Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis
Johnson, J.-E., Daley, D., Tarta, C., & Stanciu, P. (2023) · Oncology Letters · doi:10.3892/ol.2023.13754 · Cited by 78
Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: A meta-analysis
li, J., Liu, R., Tang, S., Feng, F., Liu, C., Wang, L., Zhao, W., Zhang, T., Yao, Y., Wang, X., et al. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4968-1 · Cited by 56
Li, Z., Wang, Y.-H., Wang, L.-L., Hu, D.-T., Teng, Y., Zhang, T.-Y., Yan, Z.-Y., Wang, F., & Zou, Y.-F. (2022) · Scottish Medical Journal · doi:10.1177/00369330221107099 · Cited by 40
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Yumiceba, V., López-Cortés, A., Pérez-Villa, A., Yumiseba, I., Guerrero, S., García-Cárdenas, J. M., Armendáriz-Castillo, I., Guevara-Ramírez, P., Leone, P. E., Zambrano, A. K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585130 · Cited by 40
Amiri, M., Bidhendi-Yarandi, R., Fallahzadeh, A., Marzban, Z., & Ramezani Tehrani, F. (2022) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v20i11.12357 · Cited by 31
“In addition, 7 (11, 15-17, 26, 29, 32) reported breast cancer, 6 (11, 13, 15, 27, 30, 33) reported ovarian cancer, and 6 (11, 15, 26, 28, 31, 34) reported endometrial cancer.”
Metadata
- Authors
- Zucchetto, A., Serraino, D., Polesel, J., Negri, E., De Paoli, A., Dal Maso, L., Montella, M., La Vecchia, C., Franceschi, S., & Talamini, R.
- Venue
- European Journal of Cancer Prevention
- Published
- 2009-08
- Volume
- 18
- Issue
- 4
- Pages
- 316-321
- ISSN
- 0959-8278 (ISSN-L)
- OpenAlex
- W2065677312
- Cited by
- 108
- References
- 1
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.